Amgen, Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Located in the Conejo Valley, Amgen is the world’s largest independent biotechnology firm. Amgen reported the following in a disclosure note accompanying its 2019 financial statements ($ in millions):

Also, the company disclosed that the total cost of property and equipment included $263 and $265 millions in land at the end of 2019 and 2018, respectively. In addition, the statement of cash flows for the year ended December 31, 2019, reported the following as cash flows from investing activities:

The statement of cash flows also reported 2019 depreciation and amortization of $2,206 million (depreciation of $635 and amortization of $1,571).

Required:
1. Assume that all property and equipment acquired during 2019 were purchased for cash. Determine the amount of gain or loss from sale of property and equipment that Amgen recognized during 2019.
2. Assume that Amgen uses the straight-line method to depreciate property and equipment (excluding land). What is the approximate average service life of depreciable assets?

Transcribed Image Text:

Property and equipment Less: Accumulated depreciation Property, plant, and equipment-Net 2019 $13,285 (8,357) $ 4,928 2018 $12,754 (7,796) $ 4,958